Valuation: MRI Interventions Inc

Market Cap 454M 397M 367M 338M 637M 43.74B 651M 4.38B 1.72B 21.42B 1.71B 1.67B 73.76B P/E 2026 *
-13.6x
P/E 2027 * -16.1x
Enterprise Value 454M 397M 367M 338M 637M 43.74B 651M 4.38B 1.72B 21.42B 1.71B 1.67B 73.76B EV / Sales 2026 *
8.55x
EV / Sales 2027 * 7.09x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 2017-11-06
Director of Finance/CFO 41 2020-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 68 2014-03-09
Chairman 80 2021-02-03
Director/Board Member 49 2017-11-06
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 454M
-1.97%+1.03%+25.30%+1.37% 198B
-0.58%+2.40%+4.64%-14.27% 144B
-14.15%-15.08%-33.08%-2.38% 122B
-1.32%-1.65%-57.93%-16.31% 65.44B
-2.40%-7.03%+12.54%-7.47% 49.36B
-0.11%+1.53%-24.62%-31.81% 44.75B
-3.41%-2.11%+12.98%+11.17% 37.13B
-2.44%-1.98%+24.27%+36.75% 36.23B
-4.00%-2.52%-17.27%-22.32% 28.69B
Average -0.55%-2.30%-5.91%-5.03% 80.68B
Weighted average by Cap. -3.76%-1.83%-2.45%-5.28%

Financials

2026 *2027 *
Net sales 53.13M 46.46M 42.88M 39.5M 74.49M 5.12B 76.12M 512M 201M 2.5B 200M 195M 8.63B 64.1M 56.05M 51.72M 47.65M 89.87M 6.17B 91.83M 618M 243M 3.02B 241M 235M 10.41B
Net income -33.07M -28.91M -26.68M -24.58M -46.36M -3.18B -47.37M -319M -125M -1.56B -124M -121M -5.37B -28.63M -25.04M -23.11M -21.28M -40.14M -2.76B -41.02M -276M -108M -1.35B -108M -105M -4.65B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-